Obsidian Therapeutics, Inc. OBX
Set alert
14.11 USD -0.68 -4.62%
As of Nov 2, 3:01 PM ET
13.48 Day range 14.92
11.52 52-week range 49.97
- YTD
- -19.39%
- 1 year
- -19.39%
- Open
- 14.62
- Prev close
- 14.79
- Mkt cap
- 871.92M
- Vol
- 300.94K
- Avg vol
- 386.95K
- EPS
- -1.63
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 13.48
- High
- 14.92
- Forward P/E
- -7.98
- Beta
- 2.60
- Short ratio
- 0.69
- Inst. own
- 27.36%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Mar 31, 2025
- 50-d avg
- 19.99
- 200-d avg
- 19.99
- 1y target
- 39.00
Ownership
Held by insiders 0.81%
Held by institutions 27.36%
Float held by institutions 27.58%
Institutions 5
Top institutional holders
No holders on record
Top mutual fund holders
No holders on record
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CHANG NANCY T | Director and Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | May 14, 2026 | 0 |
| EMERALD BIOVENTURES LLC | Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | May 14, 2026 | 0 |
| FRIEDMAN MICHAEL R | Director | Conversion of Exercise of derivative security | May 14, 2026 | 0 |
| SORENSEN J. MEL | Chief Executive Officer | Sale | Nov 19, 2025 | 195,029 |
| SORENSEN MELINDA | Chief Executive Officer | Sale | Nov 19, 2025 | 195,029 |
Held by funds
13 US ETFs and mutual funds hold OBX · largest positions